QuantumBio Inc. has been selected to receive a FastTrack Small Business Innovation Research Grant totaling over $865,000 from the National Institutes of Health. The project will focus on research and development of novel, quantum mechanics-based methods for the study of protein/drug interactions.
The New York NanoBusiness Alliance today announced that its President, Vincent Caprio, will embark on a national tour beginning this week to speak at a variety of business conferences, where he will address the challenges and opportunities facing those in the business of Nanotechnology.
FirstNano, a division of CVD Equipment Corporation and The City University of New York at Brooklyn College, today announced the signing of a Sponsored Research Agreement to jointly develop Zinc Oxide nano materials and related semiconductor devices.
mPhase/AlwaysReady, Inc. today said that it has successfully transferred certain processes critical to the manufacturing of its Nano Smart Battery originally developed at the New Jersey Nanotechnology Consortium to a commercial contract foundry facility.
The Berlin-based nanotechnology company Capsulution NanoScience AG has successfully completed a preclinical, in-vivo study on increasing the bio-availability of poorly water-soluble active ingredients.
Officials of NanoBioMagnetics announced the issuance of its first patent by the U.S. Patent and Trademark Office. The patent, titled ?Method and Apparatus for Improving Hearing,? is based on the use of magnetically responsive nanoparticles implanted in the organs of the middle ear to drive tissue vibrations in the amplification of sound.
Sun Microsystems, Inc. today announced that the Defense Advanced Research Projects Agency (DARPA) has awarded Sun $44.29 million funding for a five and a half-year research project focused on microchip interconnectivity via on-chip optical networks enabled by Silicon photonics and proximity communication.
What do drugs have in common with the $28 billion company's longtime business in photo film? More than you might think, according to Komori. Fujifilm wants to apply both its production expertise and nanotechnology techniques, originally developed for film production, to drugmaking.
pSivida Limited today announced that after completing its review of safety and efficacy data currently available, an independent Data Safety Monitoring Board (DSMB) has once again recommended that the two pivotal Phase III clinical trials, known collectively as the FAM (Fluocinolone Acetonide in Diabetic Macular Edema) Study can continue under the current protocol, without change.
Recognizing academic achievement in advanced XRD, Bruker AXS will present its $6,000 scholarship for the most unique application in the fields of nanotechnology, materials science, geology, or chemistry at the Fall MRS Meeting in Boston.
NanoImaging Services was founded by researchers from The Scripps Research Institute with financial support from FEI Company (Nasdaq: FEIC), a leading manufacturer of TEMs and other tools for nanotechnology.